![4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione in PDB entry 9bh5, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/9bh5_entity_81_side_image-200x200.png "Hetero 80-meric assembly 1 of PDB entry <span class='highlight'>9bh5</span> contains 1 copy of <span class='highlight'>4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione</span>. Side view.")
![4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione in PDB entry 9bh5, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/9bh5_entity_81_top_image-200x200.png "Hetero 80-meric assembly 1 of PDB entry <span class='highlight'>9bh5</span> contains 1 copy of <span class='highlight'>4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione</span>. Top view.")
Environment details NEW
3HE 3602 bound to chain A5
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.